KALA BIO INC (KALA) Fundamental Analysis & Valuation

NASDAQ:KALA • US4831192020

Current stock price

0.1731 USD
+0 (+1.23%)
At close:
0.175 USD
+0 (+1.1%)
Pre-Market:

This KALA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KALA Profitability Analysis

1.1 Basic Checks

  • KALA had negative earnings in the past year.
  • In the past year KALA has reported a negative cash flow from operations.
  • In the past 5 years KALA always reported negative net income.
  • KALA had a negative operating cash flow in each of the past 5 years.
KALA Yearly Net Income VS EBIT VS OCF VS FCFKALA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • KALA has a Return On Assets of -74.28%. This is in the lower half of the industry: KALA underperforms 65.38% of its industry peers.
  • Looking at the Return On Equity, with a value of -627.91%, KALA is doing worse than 77.76% of the companies in the same industry.
Industry RankSector Rank
ROA -74.28%
ROE -627.91%
ROIC N/A
ROA(3y)-65.78%
ROA(5y)-69.35%
ROE(3y)-371.5%
ROE(5y)-413.54%
ROIC(3y)N/A
ROIC(5y)N/A
KALA Yearly ROA, ROE, ROICKALA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KALA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KALA Yearly Profit, Operating, Gross MarginsKALA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. KALA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, KALA has more shares outstanding
  • KALA has more shares outstanding than it did 5 years ago.
  • KALA has a better debt/assets ratio than last year.
KALA Yearly Shares OutstandingKALA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
KALA Yearly Total Debt VS Total AssetsKALA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • KALA has an Altman-Z score of -19.38. This is a bad value and indicates that KALA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -19.38, KALA is doing worse than 83.37% of the companies in the same industry.
  • A Debt/Equity ratio of 2.65 is on the high side and indicates that KALA has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.65, KALA is doing worse than 78.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF N/A
Altman-Z -19.38
ROIC/WACCN/A
WACCN/A
KALA Yearly LT Debt VS Equity VS FCFKALA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

  • KALA has a Current Ratio of 1.99. This is a normal value and indicates that KALA is financially healthy and should not expect problems in meeting its short term obligations.
  • KALA has a worse Current ratio (1.99) than 76.79% of its industry peers.
  • KALA has a Quick Ratio of 1.99. This is a normal value and indicates that KALA is financially healthy and should not expect problems in meeting its short term obligations.
  • KALA has a Quick ratio of 1.99. This is in the lower half of the industry: KALA underperforms 75.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
KALA Yearly Current Assets VS Current LiabilitesKALA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. KALA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.09% over the past year.
EPS 1Y (TTM)54.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, KALA will show a very strong growth in Earnings Per Share. The EPS will grow by 25.21% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y49.59%
EPS Next 2Y38.5%
EPS Next 3Y25.21%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KALA Yearly Revenue VS EstimatesKALA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2019 2020 2021 2022 2031 2032 50M 100M 150M
KALA Yearly EPS VS EstimatesKALA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. KALA Valuation Analysis

4.1 Price/Earnings Ratio

  • KALA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year KALA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KALA Price Earnings VS Forward Price EarningsKALA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KALA Per share dataKALA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

  • KALA's earnings are expected to grow with 25.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y25.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KALA Dividend Analysis

5.1 Amount

  • No dividends for KALA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KALA Fundamentals: All Metrics, Ratios and Statistics

KALA BIO INC

NASDAQ:KALA (3/31/2026, 8:00:03 PM)

Premarket: 0.175 +0 (+1.1%)

0.1731

+0 (+1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-30
Earnings (Next)05-12
Inst Owners0.77%
Inst Owner Change38.69%
Ins Owners0.01%
Ins Owner Change-6.25%
Market Cap157.75M
Revenue(TTM)N/A
Net Income(TTM)-35.84M
Analysts45.71
Price Target1.53 (783.88%)
Short Float %0.75%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)1.58%
Max EPS beat(2)41.67%
EPS beat(4)4
Avg EPS beat(4)25.08%
Min EPS beat(4)1.58%
Max EPS beat(4)41.67%
EPS beat(8)7
Avg EPS beat(8)15.48%
EPS beat(12)7
Avg EPS beat(12)-2.76%
EPS beat(16)9
Avg EPS beat(16)-6.88%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-63.82%
EPS NQ rev (3m)-63.82%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 27.64
P/tB 27.64
EV/EBITDA N/A
EPS(TTM)-5.72
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -74.28%
ROE -627.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-65.78%
ROA(5y)-69.35%
ROE(3y)-371.5%
ROE(5y)-413.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z -19.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)113.01%
Cap/Depr(5y)128.61%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.44%
EPS Next Y49.59%
EPS Next 2Y38.5%
EPS Next 3Y25.21%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.7%
OCF growth 3YN/A
OCF growth 5YN/A

KALA BIO INC / KALA Fundamental Analysis FAQ

What is the fundamental rating for KALA stock?

ChartMill assigns a fundamental rating of 1 / 10 to KALA.


What is the valuation status for KALA stock?

ChartMill assigns a valuation rating of 1 / 10 to KALA BIO INC (KALA). This can be considered as Overvalued.


Can you provide the profitability details for KALA BIO INC?

KALA BIO INC (KALA) has a profitability rating of 0 / 10.


What is the expected EPS growth for KALA BIO INC (KALA) stock?

The Earnings per Share (EPS) of KALA BIO INC (KALA) is expected to grow by 49.59% in the next year.